ORPHA:66529
Tako-Tsubo cardiomyopathy
Also known as: Ampulla cardiomyopathy · Apical ballooning syndrome · Ballooning cardiomyopathy · Broken heart syndrome · Stress cardiomyopathy · Tako-Tsubo syndrome · Takotsubo cardiomyopathy · Takotsubo syndrome · Transient left ventricular apical ballooning syndrome
Publications
15,855
Trials
22
Interventional, condition-specific
Researchers
1,087
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
A rare cardiac disease characterized by acute occurrence of heart failure after an emotional or physical trigger; recovery of the wall motion abnormalities are observed within months. Symptoms are similar to acute coronary syndrome (ACS).
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0019018
- MeSH:D054549
- UMLS:C1739395
- NCIT:C85181
Additional Mondo synonyms (7)
Takotsubo Cardiomyopathy · ampulla cardiomyopathy · apical ballooning syndrome · ballooning cardiomyopathy · broken heart syndrome · stress cardiomyopathy · transient left ventricular apical ballooning syndrome
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
15,855 matched papers (11,089 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPresent
22 matched on ClinicalTrials.gov (8 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
15,855
15,855 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
15,855 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
11,089 in the last 10 years · low confidence
Phrase hits: 15,855 · MeSH hits: 214
Who's working on it?
1,087
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Arcari L8 papers · 2026
Cardiology Unit, Madre Giuseppina Vannini Hospital, Rome, Italy; Department of General Surgery and Surgical Speciality Paride Stefanini, Sapienza University of Rome, Rome, Italy. Electronic address: luca.arcari88@gmail.com.
Papers in Europe PMC - 02Cacciotti L5 papers · 2026
Cardiology Unit, Madre Giuseppina Vannini Hospital, Rome, Italy. Electronic address: lcuccc@libero.it.
Papers in Europe PMC - 03Cau R4 papers · 2026
Department of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), Cagliari, Italy.
Papers in Europe PMC - 04Ciolina F4 papers · 2026
Cardiology Unit, Madre Giuseppina Vannini Hospital, Rome, Italy.
Papers in Europe PMC - 05Eitel I4 papers · 2026
Medical Clinic II (Cardiology/Angiology/Intensive Care Medicine) and German Center for Cardiovascular Research (DZHK), University Heart Center Lübeck, partner site Hamburg/Kiel/Lübeck, Lübeck, Germany. Electronic address: ingo.eitel@uksh.de.
Papers in Europe PMC - 06Galea N4 papers · 2026
Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, Rome, Italy.
Papers in Europe PMC - 07Liu K4 papers · 2026
Division of Cardiology, Heart and Vascular Center, Washington University in St Louis, Barnes Jewish Hospital, St Louis 63110, MO, United States of America.
Papers in Europe PMC - 08Marchetti MF4 papers · 2026
Clinical Cardiology, Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.
Papers in Europe PMC - 09Montisci R4 papers · 2026
Clinical Cardiology, Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.
Papers in Europe PMC - 10Pontone G4 papers · 2026
Department of Perioperative Cardiology and Cardiovascular Imaging, Centro Cardiologico Monzino IRCCS, 20138 Milan, Italy.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
22
interventional trials for this specific condition
22 interventional trials matched this specific condition name; 8 currently recruiting in our sample. 704 trials are registered for cardiomyopathy, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 27 July 2026
22 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 94.8th percentile).
low confidence · 94.8th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
22 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT07491718·RECRUITING·Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Cardiomyopathy
Conditions: Takotsubo Cardiomyopathy·Matched via name + MeSH
- NCT04666454·RECRUITING·BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome.
Conditions: Takotsubo Syndrome·Matched via name phrase
- NCT06332859·RECRUITING·Effectiveness of a Resilience-Based Rehabilitation Program for Patients With Coronary Heart Disease
Conditions: Takotsubo Cardiomyopathy · Acute Coronary Syndrome · Psychological Resilience·Matched via name + MeSH
- NCT05793008·RECRUITING·Characterization of priMary And sEcondary STress Related takOtsubo
Conditions: Takotsubo Cardiomyopathy · Sepsis-induced Cardiomyopathy·Matched via name + MeSH
- NCT04513054·RECRUITING·Is There a Genetic Predisposition for Acute Stress-induced (Takotsubo) Cardiomyopathy
Conditions: Takotsubo Cardiomyopathy·Matched via name + MeSH
- NCT06509074·NOT YET RECRUITING·Beta-Blockers in Takotsubo Syndrome Study
Conditions: Takotsubo Cardiomyopathy · Beta-blockers · Echocardiography · Left Ventricular Function·Matched via name + MeSH
- NCT05946772·RECRUITING·Cyclosporine In Takotsubo Syndrome
Conditions: Takotsubo Cardiomyopathy·Matched via name + MeSH
- NCT05977049·RECRUITING·Psychosocial Support for Patients With Takotsubo Syndrome
Conditions: Takotsubo Cardiomyopathy·Matched via name + MeSH
Broader category: cardiomyopathy
704
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT07415642·NOT YET RECRUITING·Dilated Cardiomyopathy - Unknown Therapeutic Risk Reduction by Contempary Medication and Implantable Cardioverter-Defibrillators (DUTCH-ICD)
Conditions: Sudden Cardiac Death·Matched via name phrase
- NCT06635863·ENROLLING BY INVITATION·Comparing Immune System Suppression to Medication for Unexplained Heart Function and Irregular Heartbeat
Conditions: Ventricular Arrythmia · Non-ischemic Cardiomyopathy · Arrhythmogenic Inflammatory Cardiomyopathy·Matched via name phrase
- NCT05394506·RECRUITING·Modifying Factors in Striated Muscle Laminopathies
Conditions: Laminopathies · Emery Dreifuss Muscular Dystrophy 2 · LMNA-Related Congenital Muscular Dystrophy · Dilated Cardiomyopathy-1A·Matched via name phrase
- NCT04476901·RECRUITING·Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
Conditions: Non-ischemic Dilated Cardiomyopathy·Matched via name phrase
- NCT06593327·RECRUITING·NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
Conditions: Type 2 Diabetes · Diabetic Cardiomyopathy · Heart Failure · Cardiometabolic Diseases·Matched via name phrase
- NCT05511246·RECRUITING·Venous Ethanol for Ventricular Tachycardia
Conditions: Ventricular Tachycardia · Ischemic Cardiomyopathy·Matched via name phrase
- NCT07675668·NOT YET RECRUITING·Aom0304 in Adult Patients With Symptomatic Hypertrophic Cardiomyopathy
Conditions: Hypertrophic Cardiomyopathy (HCM) · Obstructive HCM (oHCM) · Non-obstructive HCM (nHCM)·Matched via name phrase
- NCT06158698·RECRUITING·CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine
Conditions: Cardiomyopathies · Myocarditis · Inflammatory Cardiomyopathy · Heart Failure·Matched via name phrase
- NCT05632432·RECRUITING·Atrial Appendage Micrograft Transplants to Assist Heart Repair After Cardiac Surgery
Conditions: Ischemic Heart Disease · Ischemic Cardiomyopathy · Heart Failure, Systolic · Heart Failure NYHA Class III·Matched via name phrase
- NCT06745206·NOT YET RECRUITING·Recombinant Human Brain Natriuretic Peptide for the Recovery Stage of Septic Shock
Conditions: Sepsis-induced Cardiomyopathy · the Recovery Phase of Septic Shock·Matched via name phrase
- NCT05302271·RECRUITING·Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia
Conditions: Friedreich Ataxia · Cardiomyopathies · Cardiac Hypertrophy · Myocardial Fibrosis·Matched via name phrase
- NCT07322237·RECRUITING·DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis
Conditions: Cirrhotic Cardiomyopathy · Empagliflozin · Cardiometabolic Risk Factors · Cirrhosis·Matched via name phrase
- NCT07600177·RECRUITING·Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic Cardiomyopathy
Conditions: Hypertrophic Cardiomyopathy (HCM)·Matched via name phrase
- NCT07052903·RECRUITING·TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Conditions: Transthyretin Amyloidosis With Cardiomyopathy·Matched via name phrase
- NCT06377033·RECRUITING·Using the EHR to Advance Genomic Medicine Across a Diverse Health System
Conditions: Genetic Predisposition · Paraganglioma · Pheochromocytoma · ALS·Matched via name phrase
Observational and natural-history studies
36 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT06277297·RECRUITING·Prognotic Role of CMR in Takotsubo Syndrome
Conditions: Takotsubo Cardiomyopathy · Machine Learning · Magnetic Resonance Imaging·Matched via name + MeSH
- NCT03299569·RECRUITING·Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland
Conditions: Takotsubo Cardiomyopathy · Myocardial Infarction·Matched via name + MeSH
- NCT04361994·RECRUITING·The GErman Italian Spanish Takotsubo (GEIST) Registry
Conditions: Takotsubo Syndrome·Matched via name phrase
- NCT06506071·RECRUITING·Characterization of Acute Myocardial Damage With Spectral Computed Tomography. (CADAMI-SPECTRAL)
Conditions: Myocarditis; Acute or Subacute · Takotsubo Cardiomyopathy · Infarction, Myocardial · Myocardial Injury·Matched via name + MeSH
- NCT06954103·RECRUITING·Mechanisms And Prognosis of Stroke-Heart Syndrome
Conditions: Stroke · Myocardial Injury · Heart Failure · Acute Coronary Syndromes·Matched via name phrase
- NCT06669962·RECRUITING·Characterisation of the Biochemical Profile and Physiology of the Coronary Circulation in Takotsubo Syndrome
Conditions: Tako Tsubo Cardiomyopathy·Matched via name phrase
- NCT03663348·RECRUITING·Registry of Patients With Takotsubo Syndrome
Conditions: Takotsubo Cardiomyopathy · Broken Heart Syndrome · Tako-tsubo Cardiomyopathy·Matched via name + MeSH
- NCT06597331·RECRUITING·Cardiac Assessment and Takotsubo-stunning Among COPD-exacerbations In-Hospital
Conditions: Chronic Obstructive Pulmonary Disease · Takotsubo Cardiomyopathy · Acute Heart Failure·Matched via name + MeSH
- NCT05731830·RECRUITING·Takotsubo Syndrome and Air Pollution
Conditions: Takotsubo Syndrome·Matched via name phrase
- NCT06409585·RECRUITING·Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition
Conditions: Heart Failure With Preserved Ejection Fraction · Hypertrophic Cardiomyopathy · Cardiac Sarcoidosis · Hypertensive Heart Disease·Matched via name phrase
- NCT07077304·RECRUITING·EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases
Conditions: Myocarditis · ANCA Associated Vasculitis · Pericarditis · Systemic Sclerosis·Matched via name phrase
- NCT03910569·RECRUITING·The Cedars-Sinai Smidt Heart Institute Takotsubo Registry & Proteomic Study
Conditions: Takotsubo Cardiomyopathy·Matched via name + MeSH
- NCT04634487·RECRUITING·Polish Registry of Takotsubo Syndrome
Conditions: Takotsubo Syndrome·Matched via name phrase
- NCT07604467·RECRUITING·The Role of CD34+ Stem Cells in the Pathogenesis of Takotsubo Syndrome
Conditions: Tako Tsubo Cardiomyopathy · Microvascular Dysfunction · CD34+ Stem Cells · Heart Failure·Matched via name phrase
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Tako-Tsubo cardiomyopathy" OR "Ampulla cardiomyopathy" OR "Apical ballooning syndrome" OR "Ballooning cardiomyopathy" OR "Broken heart syndrome" OR "Stress cardiomyopathy" OR "Tako-Tsubo syndrome" OR "Takotsubo cardiomyopathy" OR "Takotsubo syndrome" OR "Transient left ventricular apical ballooning syndrome"
MeSH descriptor terms unioned into the query: Takotsubo Cardiomyopathy
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Tako-Tsubo cardiomyopathy" OR "Ampulla cardiomyopathy" OR "Apical ballooning syndrome" OR "Ballooning cardiomyopathy" OR "Broken heart syndrome" OR "Stress cardiomyopathy" OR "Tako-Tsubo syndrome" OR "Takotsubo cardiomyopathy" OR "Takotsubo syndrome" OR "Transient left ventricular apical ballooning syndrome"
Interventional trials matched via: both, phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 22 interventional · 36 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"cardiomyopathy"
Query health: ok — strategies attempted: phrase, mesh; with hits: phrase, mesh
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (15855) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-27T01:20:36.272Z
